Trial Profile
A Randomised controlled Trial of Dabigatran Etexilate on airway inflammation and coagulation in severe COrticosteroid dependent asthma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Asthma; Venous thromboembolism
- Focus Biomarker; Pharmacodynamics
- Acronyms ARTDECO
- 14 Mar 2012 New trial record